| Quarterly Financials | Mar 2015 | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 |
Revenue  | 1,085 | 1,152 | 1,150 | 1,024 | 1,106 | 1,176 | 1,257 | 1,630 | 1,164 | 1,229 | 1,258 | 1,175 | 1,108 | 1,081 | 1,156 | 1,164 | 1,528 | 1,170 | 1,277 | 1,178 | 1,133 | 614 | 1,029 | 1,205 | 1,278 | 1,733 | 1,475 | 1,487 | 1,391 | 1,519 | 1,682 | 1,586 | 1,669 | 1,667 | 1,788 | 1,699 | 1,803 | 1,873 | 2,006 | 1,975 | 2,032 |
| Expenses | 1,022 | 986 | 1,087 | 1,066 | 1,091 | 1,059 | 1,097 | 1,023 | 1,045 | 1,071 | 1,138 | 1,069 | 1,907 | 1,034 | 1,172 | 1,193 | 1,069 | 996 | 1,028 | 1,012 | 987 | 709 | 875 | 987 | 1,055 | 1,135 | 1,178 | 1,180 | 1,157 | 1,237 | 1,304 | 1,283 | 1,372 | 1,386 | 1,440 | 1,396 | 1,405 | 1,516 | 1,613 | 1,553 | 1,625 |
| EBITDA | 62 | 166 | 62 | -42 | 15 | 118 | 160 | 607 | 118 | 158 | 120 | 106 | -799 | 47 | -16 | -29 | 459 | 174 | 250 | 166 | 146 | -96 | 155 | 218 | 223 | 598 | 297 | 307 | 234 | 282 | 378 | 302 | 297 | 282 | 349 | 303 | 398 | 356 | 393 | 422 | 406 |
| Operating Profit % | 3 % | 4 % | -2 % | -5 % | -2 % | 6 % | 8 % | 10 % | 7 % | 7 % | 5 % | 5 % | -76 % | 1 % | -3 % | -8 % | 10 % | 13 % | 15 % | 13 % | 11 % | -17 % | 12 % | 16 % | 16 % | 20 % | 19 % | 20 % | 16 % | 17 % | 19 % | 18 % | 16 % | 16 % | 19 % | 17 % | 21 % | 18 % | 19 % | 19 % | 19 % |
| Depreciation | 61 | 53 | 0 | 0 | 72 | 48 | 52 | 60 | 63 | 59 | 61 | 59 | 60 | 57 | 56 | 60 | 60 | 71 | 71 | 70 | 80 | 72 | 74 | 73 | 72 | 73 | 75 | 76 | 77 | 74 | 77 | 83 | 82 | 79 | 84 | 87 | 92 | 91 | 95 | 97 | 102 |
| Interest | 37 | 34 | 30 | 32 | 38 | 42 | 46 | 75 | 67 | 64 | 66 | 63 | 64 | 76 | 85 | 111 | 65 | 51 | 49 | 48 | 57 | 41 | 42 | 42 | 41 | 38 | 40 | 38 | 30 | 31 | 33 | 33 | 32 | 32 | 32 | 33 | 35 | 35 | 36 | 45 | 68 |
| Profit Before Tax | -22 | 88 | 44 | -58 | -96 | 28 | 62 | 472 | -11 | 35 | -7 | -17 | -924 | -87 | -157 | -201 | 334 | 52 | 130 | 48 | 9 | -208 | 38 | 103 | 110 | 486 | 182 | 193 | 126 | 176 | 268 | 186 | 183 | 171 | 233 | 183 | 271 | 230 | 261 | 279 | 237 |
| Tax | -10 | -9 | -17 | -29 | -8 | 3 | 24 | 19 | 26 | 12 | 17 | 3 | -9 | -34 | -15 | -20 | 183 | -26 | 6 | 118 | 50 | -20 | 23 | 49 | 48 | 56 | 51 | 51 | 39 | 42 | 50 | 44 | 45 | 47 | 49 | 49 | 68 | 56 | 68 | 25 | 49 |
| Net Profit | -12 | 97 | 61 | -29 | -88 | 25 | 38 | 453 | -38 | 23 | -24 | -19 | -914 | -53 | -142 | -180 | 151 | 78 | 124 | -69 | -41 | -188 | 16 | 54 | 62 | 431 | 131 | 142 | 87 | 134 | 218 | 142 | 138 | 124 | 184 | 134 | 203 | 174 | 193 | 254 | 188 |
| EPS in ₹ | -0.38 | 2.01 | 1.19 | -0.65 | -1.91 | 0.35 | 0.68 | 9.49 | -0.79 | 0.10 | -0.88 | -0.71 | -17.97 | -1.36 | -3.21 | -3.06 | 1.80 | 0.90 | 1.47 | -1.01 | -0.59 | -2.37 | -0.05 | 0.40 | 0.57 | 3.49 | 1.42 | 1.55 | 0.90 | 1.62 | 2.71 | 1.72 | 1.76 | 1.48 | 2.30 | 1.78 | 2.37 | 2.20 | 2.34 | 3.28 | 2.44 |
Fortis Healthcare
719.05
-4.75
(-0.66%)
Market Cap
54,285.30 Cr
EPS
7.93
PE Ratio
64.11
Dividend Yield
0.14 %
Industry
Healthcare Services52 Week High
744.50
52 Week Low
406.00
PB Ratio
6.09
Debt to Equity
0.14
Sector
Hospitals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from13 analysts
Company News
View All News
Fortis Healthcare: Shares Surge 10% on Strong Growth Outlook3 days ago
Fortis Healthcare shares jumped up to 10% following positive Q4 performance and robust FY26 guidance. The company plans to add 1,976 beds by FY29, projecting 14-15% revenue growth and 150-200 bps margin expansion in its hospital business for FY26. The diagnostics segment expects double-digit revenue growth with mid-20% margins. Global brokerages Nomura and Nuvama maintain 'Buy' ratings with increased price targets.
Fortis Healthcare: Targeting Higher Margins and Steady Growth in FY264 days ago
Fortis Healthcare aims for margin improvement in FY26, supported by stable occupancy levels above 70%, increased complex procedures, and network expansion. The company plans to add 800 new beds this year and expects diagnostics margins to reach 21%. International patient revenue growth may moderate due to geopolitical uncertainty.
Fortis Healthcare Reports Q4 Financial Results and Dividend4 days ago
Fortis Healthcare announced its Q4 consolidated net profit of 1.88 billion rupees, down from 2.03 billion rupees year-over-year. Revenue increased to 20.07 billion rupees from 17.86 billion rupees in the same period last year. The company reported an exceptional loss of 535.7 million rupees compared to a profit of 31.4 million rupees in the previous year. Q4 profit before tax (PBT) rose to 2.9 billion rupees from 2.68 billion rupees year-over-year. Fortis Healthcare has recommended a final dividend of 1 rupee per equity share.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,177.10 | #1 1,14,430.80 | 101.05 | 5,584.10 | 18.77 | #1 1,058 | 26.84 | 57.57 | |
7,064.50 | 1,01,576.70 | 77.51 | #1 19,165.50 | 14.74 | 917 | 49.14 | 57.82 | |
719.05 | #3 54,285.30 | #5 64.11 | #2 6,931.20 | #10 8.99 | #4 645 | #8 -7.43 | 61.88 | |
1,724.40 | 35,240.00 | #1 44.96 | 5,093.40 | 10.96 | 790 | 3.41 | 44.82 | |
1,219.90 | 32,765.00 | 63.13 | 2,759.20 | #1 25.09 | 326 | -20.35 | 51.90 | |
553.80 | 27,663.00 | 74.55 | 3,723.70 | 22.85 | 205 | #1 3,986.36 | 56.75 | |
672.90 | 26,925.30 | 71.59 | 2,511.20 | 12.94 | 336 | 48.39 | 60.33 | |
1,352.30 | 13,732.80 | 57.70 | 1,334.00 | 10.76 | 218 | 10.57 | 45.37 | |
1,459.30 | 9,568.00 | 49.50 | 1,095.50 | 21.32 | 177 | -0.88 | 52.00 | |
594.65 | 8,290.30 | 148.78 | 1,929.10 | 12.97 | 41 | -71.06 | 55.43 |
Forecast
Actual
Growth Rate
Revenue Growth
8.99 %
Net Income Growth
1.93 %
Cash Flow Change
33.79 %
ROE
-3.46 %
ROCE
14.14 %
EBITDA Margin (Avg.)
3.01 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Total Assets | 7,616 | 7,232 | 9,717 | 8,622 | 11,951 | 11,348 | 11,155 | 11,885 | 12,434 | 13,289 |
| Fixed Assets | 4,218 | 3,776 | 5,419 | 4,992 | 8,477 | 8,802 | 8,799 | 9,416 | 9,426 | 9,874 |
| Current Assets | 1,636 | 1,434 | 1,775 | 1,282 | 1,667 | 941 | 1,037 | 1,133 | 1,406 | 1,421 |
| Capital Work in Progress | 228 | 201 | 268 | 226 | 450 | 204 | 165 | 194 | 228 | 542 |
| Investments | 616 | 1,449 | 1,878 | 1,732 | 270 | 175 | 186 | 104 | 210 | 230 |
| Other Assets | 2,554 | 1,807 | 2,152 | 1,672 | 2,755 | 2,167 | 2,005 | 2,172 | 2,569 | 2,643 |
| Total Liabilities | 7,616 | 7,232 | 9,717 | 8,622 | 11,951 | 11,348 | 11,155 | 11,885 | 12,434 | 13,289 |
| Current Liabilities | 1,602 | 1,476 | 1,927 | 2,134 | 3,591 | 2,579 | 1,233 | 1,269 | 1,426 | 3,170 |
| Non Current Liabilities | 1,813 | 1,616 | 1,480 | 1,171 | 1,248 | 1,563 | 3,204 | 3,607 | 2,907 | 1,563 |
| Total Equity | 4,201 | 4,140 | 6,311 | 5,317 | 7,113 | 7,206 | 6,718 | 7,008 | 8,100 | 8,556 |
| Reserve & Surplus | 3,585 | 3,534 | 4,626 | 3,543 | 5,846 | 5,906 | 5,365 | 5,423 | 6,487 | 6,908 |
| Share Capital | 463 | 463 | 518 | 519 | 755 | 755 | 755 | 755 | 755 | 755 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | -66 | -38 | 225 | -513 | 799 | -627 | 212 | -153 | -22 | 125 |
| Investing Activities | 213 | 122 | -1,001 | -333 | -3,279 | 64 | -131 | -501 | -373 | -889 |
| Operating Activities | 24 | 195 | 967 | 493 | -179 | 172 | 486 | 865 | 822 | 1,100 |
| Financing Activities | -304 | -354 | 259 | -672 | 4,257 | -862 | -143 | -517 | -471 | -87 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 |
| Promoter | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 26.32 % | 0.00 % | 23.24 % | 23.31 % | 25.26 % | 26.77 % | 27.40 % |
| DIIs | 13.44 % | 15.20 % | 15.66 % | 15.50 % | 16.72 % | 17.44 % | 19.94 % | 20.38 % | 20.70 % | 22.16 % | 26.55 % | 29.35 % | 31.15 % | 32.31 % | 30.73 % | 30.05 % | 29.46 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 13.96 % | 15.16 % | 15.98 % | 14.89 % | 13.96 % | 13.58 % | 12.92 % | 12.39 % | 12.05 % | 11.80 % | 11.13 % | 11.04 % | 10.82 % | 10.47 % | 10.36 % | 10.21 % | 10.22 % |
| Others | 41.43 % | 38.47 % | 37.20 % | 38.44 % | 38.15 % | 37.82 % | 35.98 % | 36.06 % | 36.08 % | 34.86 % | 4.83 % | 28.44 % | 3.63 % | 2.75 % | 2.48 % | 1.81 % | 1.75 % |
| No of Share Holders | 0 | 1,09,889 | 1,44,634 | 1,66,743 | 1,54,572 | 1,56,881 | 1,60,762 | 1,58,455 | 1,37,894 | 1,35,047 | 1,31,516 | 1,35,664 | 1,57,165 | 1,54,260 | 2,04,184 | 2,21,750 | 2,18,329 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1 | 1 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.24 | 0.14 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 20 May 2025 |  Quarterly Result Announcement | NA | 20 May 2025 | 682.75 | 685.85 |
| 07 Feb 2025 | Quarterly Result Announcement | NA | 07 Feb 2025 | 581.00 | 651.05 |
| 08 Nov 2024 | Quarterly Result Announcement | NA | 08 Nov 2024 | 601.65 | 623.10 |
| 02 Aug 2024 |  Annual General Meeting | NA | 02 Aug 2024 | 471.55 | 505.05 |
| 24 Jul 2024 |  Dividend | ₹ 1.00 /share | 24 Jul 2024 | 469.50 | 487.45 |
| 20 Jul 2023 | Dividend | ₹ 1.00 /share | 20 Jul 2023 | 289.05 | 328.75 |
Announcements
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
4 days ago
4 days agoAnnouncement under Regulation 30 (LODR)-Newspaper Publication4 days ago
4 days agoStatement Of Utilization And Deviation Or Variation In The Use Of Proceeds Of Issue Of Listed Non-Convertible Debentures (Ncds)5 days ago
5 days agoDisclosure Under Regulation 30 Of SEBI (Listing Obligations &
Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations).5 days ago
5 days agoCompliance With Respect To The Regulation 56(1)(D) Of SEBI (Listing Obligations And Disclosures Requirements) Regulations 2015 And Other Relevant Provisions.5 days ago
5 days agoAnnouncement under Regulation 30 (LODR)-Investor Presentation5 days ago
5 days agoAnnouncement under Regulation 30 (LODR)-Press Release / Media Release5 days ago
5 days agoCompliances-Reg. 54 - Asset Cover details 5 days ago
5 days agoRevision In Policies.5 days ago
5 days agoAnnouncement under Regulation 30 (LODR)-Change in Management5 days ago
5 days agoAppointment Of Secretarial Auditors And Cost Auditors.5 days ago
5 days agoCorporate Action-Board approves Dividend5 days ago
5 days agoAnnouncement under Regulation 30 (LODR)-Dividend Updates5 days ago
5 days agoAnnouncement under Regulation 30 (LODR)-Change in Management5 days ago
5 days agoOutcome Of The Board Meeting Under Regulation 30 33 51(2) And Regulation 52 Of Securities And Exchange Board Of India (Listing Obligations & Disclosure Requirements) Regulations 20155 days ago
5 days agoBoard Meeting Outcome for Outcome Of The Board Meeting Under Regulation 30 33 51(2) And Regulation 52 Of Securities And Exchange Board Of India (Listing Obligations & Disclosure Requirements)
Regulations 20155 days ago
5 days agoReschedule Of Investors/ Ananlysts Call9 days ago
9 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation9 days ago
9 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 09, 2025
May 09, 2025Board Meeting Intimation for Notice Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015May 08, 2025
May 08, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligation & Disclosure Requirements) Regulations 2015May 05, 2025
May 05, 2025Disclosure Under Chapter XIV - Centralized Database For Corporate Bonds/ Debentures Of SEBI Master Circular Dated May 22 2024.Apr 30, 2025
Apr 30, 2025Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 25, 2025
Apr 25, 2025Compliances-Half Yearly Report (SEBI Circular No. CIR/IMD/DF-1/67/2017) Apr 10, 2025
Apr 10, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Apr 03, 2025
Apr 03, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 03, 2025
Apr 03, 2025Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderApr 02, 2025
Apr 02, 2025Disclosure Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) - Regarding Fortis Trademarks And Allied Trademarks.Apr 02, 2025
Apr 02, 2025Closure of Trading WindowMar 26, 2025
Mar 26, 2025Announcement under Regulation 30 (LODR)-Updates on AcquisitionMar 21, 2025
Mar 21, 2025Update On Acquisition Announcement Dated February 14 2025Mar 21, 2025
Mar 21, 2025 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMar 20, 2025
Mar 20, 2025Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotMar 20, 2025
Mar 20, 2025Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015.Mar 20, 2025
Mar 20, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 19, 2025
Feb 19, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotFeb 18, 2025
Feb 18, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 14, 2025
Feb 14, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 14, 2025
Feb 14, 2025Acquisition Of Shrimann Superspecialty Hospital.Feb 14, 2025
Feb 14, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 14, 2025
Feb 14, 2025Announcement under Regulation 30 (LODR)-AcquisitionFeb 14, 2025
Feb 14, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 10, 2025
Feb 10, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 08, 2025
Feb 08, 2025Statement Of Deviation And Variation.Feb 07, 2025
Feb 07, 2025Announcement under Regulation 30 (LODR)-Investor PresentationFeb 07, 2025
Feb 07, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 07, 2025
Feb 07, 2025Compliances-Reg. 54 - Asset Cover details Feb 07, 2025
Feb 07, 2025Integrated Filing (Financial)Feb 07, 2025
Feb 07, 2025Updated Policy Of Materiality Of EventsFeb 07, 2025
Feb 07, 2025Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationFeb 07, 2025
Feb 07, 2025Technical Indicators
RSI(14)
Neutral 61.88
ATR(14)
Less Volatile 26.20
STOCH(9,6)
Neutral 64.79
STOCH RSI(14)
Neutral 62.87
MACD(12,26)
Bullish 2.63
ADX(14)
Weak Trend 19.71
UO(9)
Bearish 51.96
ROC(12)
Uptrend And Accelerating 5.32
WillR(14)
Neutral -23.56
About Fortis Healthcare
Fortis Healthcare Limited is one of India's largest healthcare providers, operating 27 hospitals with 4,500 operational beds and over 426 diagnostics centres as of March 31, 2023. The company offers a wide range of integrated healthcare services including cardiac care, orthopedics, neurosciences, oncology, renal care, gastroenterology, and mother and child care. Fortis uses advanced technology to deliver quality healthcare in modern facilities. Its subsidiary, SRL Limited, is a leading diagnostics chain in India. Fortis Healthcare has a presence in India, Dubai, Mauritius, and Sri Lanka. The company has expanded through acquisitions and new facility launches over the years, focusing on its core Indian market in recent times. It provides inpatient and outpatient services, sells medical and non-medical items, and offers management services to hospitals. Fortis Healthcare's specialties include cardiac sciences, cosmetology, dental sciences, dermatology, general surgery, oncology, urology, neurosurgery, radiology, orthopedics, and organ transplant.
Listing Date
09 May, 2007(18 Years,
17 days)
Chairperson NameLeo Puri
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
